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ABSTRACT
Study queStion
What are the diagnostic yield and accuracy of early 
computed tomography (CT) angiography followed by 
magnetic resonance imaging/angiography (MRI/MRA) 
and digital subtraction angiography (DSA) in patients 
with non-traumatic intracerebral haemorrhage?
MethodS
This prospective diagnostic study enrolled 298 adults 
(18-70 years) treated in 22 hospitals in the Netherlands 
over six years. CT angiography was performed within 
seven days of haemorrhage. If the result was negative, 
MRI/MRA was performed four to eight weeks later. DSA 
was performed when the CT angiography or MRI/MRA 
results were inconclusive or negative. The main 
outcome was a macrovascular cause, including 
arteriovenous malformation, aneurysm, dural 
arteriovenous fistula, and cavernoma. Three blinded 
neuroradiologists independently evaluated the images 
for macrovascular causes of haemorrhage. The 
reference standard was the best available evidence 
from all findings during one year’s follow-up.
Study anSwer and liMitationS
A macrovascular cause was identified in 69 patients 
(23%). 291 patients (98%) underwent CT angiography; 214 
with a negative result underwent additional MRI/MRA and 
97 with a negative result for both CT angiography and 
MRI/MRA underwent DSA. Early CT angiography detected 
51 macrovascular causes (yield 17%, 95% confidence 
interval 13% to 22%). CT angiography with MRI/MRA 
identified two additional macrovascular causes (18%, 
14% to 23%) and these modalities combined with DSA 
another 15 (23%, 18% to 28%). This last extensive strategy 
failed to detect a cavernoma, which was identified on MRI 
during follow-up (reference strategy). The positive 
predictive value of CT angiography was 72% (60% to 
82%), of additional MRI/MRA was 35% (14% to 62%), and 
of additional DSA was 100% (75% to 100%). None of the 
patients experienced complications with CT angiography 
or MRI/MRA; 0.6% of patients who underwent DSA 
experienced permanent sequelae. Not all patients with 
negative CT angiography and MRI/MRA results underwent 
DSA. Although the previous probability of finding a 
macrovascular cause was lower in patients who did not 
undergo DSA, some small arteriovenous malformations or 
dural arteriovenous fistulas may have been missed.
what thiS Study addS
CT angiography is an appropriate initial investigation 
to detect macrovascular causes of non-traumatic 
intracerebral haemorrhage, but accuracy is modest. 
Additional MRI/MRA may find cavernomas or 
alternative diagnoses, but DSA is needed to diagnose 
macrovascular causes undetected by CT angiography 
or MRI/MRA.
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Introduction
Non-traumatic intracerebral haemorrhage accounts 
for 10-15% of all strokes1 2  and arises from an underly-
ing macrovascular cause, including arteriovenous 
 malformation, aneurysm, dural arteriovenous fistula, 
cavernoma, and cerebral venous sinus thrombosis in 
WhAT IS AlReAdy knoWn on ThIS TopIC
Large variability exists in the diagnostic approach to identify a macrovascular cause 
in patients with intracerebral haemorrhage (ICH)
The diagnostic accuracy of both CT angiography and MRI/MRA (with digital 
subtraction angiography (DSA) as the reference standard) seems high, but 
methodological shortcomings of previous studies may have led to overestimation 
of diagnostic accuracy
Baseline clinical and radiological characteristics, such as (absence of) 
hypertension and lobar haematoma location, seem useful to identify patients with 
a high likelihood of an underlying macrovascular cause
WhAT ThIS STudy AddS
Accuracy of CT angiography for the detection of macrovascular causes of ICH is 
modest, less than previously assumed, and warrants digital subtraction 
angiography when the result of CT angiography is negative 
The additional value of MRI/MRA after negative CT angiography consists mainly of 
diagnosis of non-macrovascular causes of ICH
Both posterior fossa location in the absence of hypertension and the absence of 
signs of small vessel disease on non-contrast CT seem to be independent 
predictors of an underlying macrovascular cause of ICH
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1 of 4 to 1 of 7 patients.3-5  Detection of these macrovas-
cular causes is vital as this may have immediate ther-
apeutic and prognostic implications.6  The best 
strategy for identifying a macrovascular cause in 
patients with non-traumatic intracerebral haemor-
rhage is unknown. Following the identification of 
non-traumatic intracerebral haemorrhage on 
non-contrast computed tomography (CT), immediate 
angiographic assessment using CT angiography is 
easy to perform; this procedure is widely available in 
the Netherlands. The additional diagnostic value of 
magnetic resonance imaging/magnetic resonance 
angiography (MRI/MRA) in patients with negative CT 
angiography results is unknown, as is the additional 
value of digital subtraction angiography after a nega-
tive result for CT angiography or for both CT angiogra-
phy and MRI/MRA. Baseline patient and non-contrast 
CT characteristics, such as age less than 45 years and 
lobar location of the haemorrhage seem useful for 
identifying those with a high likelihood of an underly-
ing macrovascular cause,4 7-9  but there are no reliable 
data on how to select patients for (invasive) angio-
graphic examination.10-12  Consequently, large variabil-
ity exists in the diagnostic approach of patients with 
non-traumatic intracerebral haemorrhage.13
We determined the diagnostic yield and accuracy of 
CT angiography as a single modality performed in the 
acute phase after non-contrast CT; the yield of CT 
angiography and MRI/MRA combined; the yield of CT 
angiography, MRI/MRA, and digital subtraction angi-
ography combined; and the additional accuracy of 
MRI/MRA and of digital subtraction angiography in 
patients with a negative CT angiography result. We 
also investigated the influence of patient and radiolog-
ical characteristics on the probability of finding an 
underlying macrovascular cause.
Methods
Setting
The prospective, multicentre DIagnostic AngioGRAphy 
to find vascular Malformations (DIAGRAM) study 
included patients with non-traumatic intracerebral hae-
morrhage aged between 18 and 70 years, treated in 22 
participating hospitals in the Netherlands between July 
2008 and June 2014. Inclusion criteria were indepen-
dence before stroke, defined as a modified Rankin score 
<314  and the ability to undergo investigations. We 
excluded patients aged more than 45 years with hyper-
tension and non-traumatic intracerebral haemorrhage in 
the basal ganglia, thalamus, or posterior fossa, because 
of the low probability of finding an underlying macrovas-
cular cause.8  Patients were considered to have hyperten-
sion when at least one of three criteria was met: 
documented history of hypertension, use of antihyper-
tensive drugs before the non-traumatic intracerebral hae-
morrhage, or evidence of left ventricular hypertrophy on 
an admission electrocardiogram (Sokolow-Lyon crite-
ria).15  Other exclusion criteria were a diagnosis of a 
known macrovascular abnormality or tumour estab-
lished before the haemorrhage occurred, and use of oral 
anticoagulants with an international normalised ratio of 
more than 2.5 at the time of the haemorrhage. For risk 
assessment, we collected data on clinical condition at 
admission, smoking, alcohol consumption, drug misuse, 
patient and family history of cardiovascular disease, dia-
betes mellitus, use of anticoagulants or platelet inhibi-
tors, use of antihypertensive drugs, and serum lipid 
levels. We defined high alcohol intake as consumption of 
four or more units a day.16 All participants provided writ-
ten informed consent for inclusion in the study.
procedures
Patients underwent CT angiography within seven days of 
the non-traumatic intracerebral haemorrhage, preferably 
within 48 hours after non-contrast CT. If the result of CT 
angiography was negative, MRI/MRA was performed four 
to eight weeks after the haemorrhage, or earlier if indi-
cated clinically. Patients underwent digital subtraction 
angiography when the results of CT angiography or MRI/
MRA were inconclusive or negative. Digital subtraction 
angiography was also performed in patients with an arte-
riovenous malformation or dural arteriovenous fistula 
found on CT angiography or MRI/MRA, to plan treatment. 
Digital subtraction angiography was not mandatory if an 
aneurysm,17  a cerebral venous sinus thrombosis, or an 
underlying cavernoma was identified by CT angiography 
or MRI/MRA.18 All patients were followed for at least one 
year by  telephone interviews at four weeks, three months, 
and 12 months after the onset of the haemorrhage, to 
obtain information on complications of diagnostic proce-
dures, recurrent non-traumatic intracerebral haemor-
rhage, and findings of angiographic assessment, 
follow-up imaging, neurosurgical inspection, and patho-
logical examination. For patients with a follow-up of lon-
ger than 12 months during the study period as part of 
 clinical practice, we collected data on recurrent non- 
traumatic intracerebral haemorrhage during this 
extended follow-up and an underlying cause if found.
Imaging protocols
CT angiography was performed using a multidetec-
tor CT scanner with 16 or more slices. An unen-
hanced and late enhanced brain CT with 6 mm 
maximum slice thickness were performed as well as 
a CT angiography with contrast timing, from level C2 
of the cervical spine upwards to the vertex.
MRI/MRA studies were done on 1.5T or 3T magnetic 
resonance scanners and included a sagittal T1 
weighted scan, transversal T1 weighted scan, T2 tur-
bo-spin-echo, and T2 gradient echo scans, 3D mul-
tichunk gradient-echo time-of-flight MRI/MRA after a 
single dose (0.1 mmol/kg) of intravenous gadolinium 
contrast injection to increase distal vessel and venous 
opacification, and a transversal 3D T1 weighted con-
trast enhanced scan.
Digital subtraction angiography consisted of selec-
tive catheterisation of the internal and external carotid 
arteries or vertebral artery of the symptomatic hemi-
sphere. On the asymptomatic side, the common carotid 
artery was catheterised, with further catheterisation of 
the internal and external carotid arteries if abnormali-
ties were seen. Participating sites that did not routinely 
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perform cerebral digital subtraction angiography 
referred their patients to centres with this expertise.
We collected data on complications of the investigations 
(type of complication and clinical consequences). We 
asked all participating centres to adhere to these imaging 
protocols, with allowance of some local variation.
Radiological assessment
Two of three experienced neuroradiologists (BKV, 
GAPdK, or TDW) independently assessed the images of 
each non-contrast CT, CT angiography, and MRI/MRA, 
blinded to age, sex, and clinical characteristics of the 
patients. The neuroradiologists reported on the charac-
teristics of the haematoma, signs of small vessel disease 
or previous infarcts on non-contrast CT (see supple-
mentary box 1), and presence of microbleeds or old 
non-traumatic intracerebral haemorrhage on MRI. We 
defined signs of small vessel disease on non-contrast 
CT as the presence of white matter lesions, or an infarct 
in basal ganglia, thalamus, or posterior fossa. A third 
observer resolved differences between readings.
When additional digital subtraction angiography 
was performed, a third assessment was done (GAPdK) 
to review the combination of CT angiography, MRI/
MRA, and digital subtraction angiography. The volume 
of non-traumatic intracerebral haemorrhage was calcu-
lated with Analyze software (Biomedical Imaging 
Resource, Mayo Clinic, Rochester, MN), not including 
perihaematomal oedema.
Statistical analysis
The main outcome measure was the presence of a macro-
vascular cause, including arteriovenous malformation, 
aneurysm, dural arteriovenous fistula, developmental 
venous anomaly, cerebral venous sinus thrombosis, and 
cavernoma. The reference standard was the best available 
evidence from all findings during one year of follow-up.
We calculated the probability of detection of a macro-
vascular cause in both the presence and the absence of 
clinical and radiological characteristics, and calculated 
prevalence ratios with 95% confidence intervals for 
each characteristic. Diagnostic accuracy measures were 
calculated twice: first with inconclusive results 
regarded as a positive outcome and subsequently with 
inconclusive results regarded as a negative outcome, 
with 95% confidence intervals. We calculated the diag-
nostic yield of CT angiography as a single modality, of 
combined CT angiography and MRI/MRA, and of com-
bined CT angiography, MRI/MRA, and digital subtrac-
tion angiography, with 95% confidence intervals. In the 
calculation of yield of the diagnostic strategy, we 
included patients in whom no MRI/MRA or digital sub-
traction angiography was performed because the previ-
ous modality had revealed a macrovascular cause.
Sample size calculations
Based on the literature, we estimated the prevalence of 
macrovascular abnormalities in the study domain to be 
40%.8 Estimated sensitivity and specificity of CT angiog-
raphy, MRI/MRA, and digital subtraction angiography 
for the detection of macrovascular causes were based on 
a retrospective pilot study of 451 patients who had been 
admitted to the University Medical Center Utrecht 
because of non-traumatic intracerebral haemorrhage 
between 1990 and 1998. Digital subtraction angiography 
showed a vascular malformation as cause of the haem-
orrhage in 30 (27%, 95% confidence interval 19% to 
35%) of the 112 patients in whom either a CT angiogra-
phy or MRI/MRA result was negative. We estimated a 
sensitivity of 50% and a specificity of 95% for the combi-
nation of CT angiography and MRI/MRA for detecting a 
macrovascular cause, and 95% and 98%, respectively, 
for digital subtraction angiography. Thus we expected to 
find a positive predictive value of 87% (95% confidence 
interval 77% to 94%) for CT angiography and MRI/MRA 
and 97% (92% to 99%) for digital subtraction angiogra-
phy. This would mean an increase in positive predictive 
value of digital subtraction angiography in comparison 
with CT angiography and MRI/MRA of 10% (1% to 18%). 
The negative predictive value would increase even more, 
by 23% (17% to 29%) comparing digital subtraction 
angiography (97%, 93% to 99%) and the combination of 
CT angiography and MRI/MRA (74%, 68% to 80%).
We aimed to build a multivariable logistic regression 
model with a maximum of 12 predictors. Based on the 
rule of thumb that each predictor would need 10 out-
comes,19 we therefore required 120 patients with an 
underlying macrovascular cause, a sample size of 300 
patients in total.
Multivariable logistic regression
With a multivariable logistic regression model we 
assessed which of six predefined determinants (patient 
characteristics: age as a continuous variable, hyperten-
sion, current smoking, heavy drinking, and radiological 
characteristics: deep, lobar, or posterior fossa location; 
and signs of small vessel disease on non-contrast CT) 
discerned best between the presence and absence of a 
macrovascular cause. Missing values were imputed for 
alcohol consumption and smoking.19  We used restricted 
cubic spline functions and graphs to decide whether 
age could be analysed as a linear term or needed trans-
formation.20 We selected variables for the final multi-
variable regression model with a backward selection 
procedure (exclusion if P>0.20).
Analyses were performed with IBM SPSS Statistics 
(version 21.0) and R 2.15.2 software. Results are reported 
according to the standards for reporting of diagnostic 
accuracy criteria for diagnostic tests.21
patient involvement
No patients were involved in setting the research ques-
tion or the outcome measures, nor were they involved in 
the design and implementation of the study. There are no 
plans to involve patients in dissemination of the results.
Results
Overall, 302 patients were included in the study 
between July 2008 and July 2014. In three patients, CT 
angiography was not performed and in one patient MRI 
was contraindicated (protocol violations); these four 
patients were excluded from further analyses.
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The mean age of the remaining 298 patients was 53.0 
years (SD 11.5 years), and the median volume of 
non-traumatic intracerebral haemorrhage was 11 mL 
(interquartile range 4-26 mL). According to the reference 
standard, 69 patients (23%) had an underlying macro-
vascular cause (table 1). In 68 patients a macrovascular 
cause was identified by the diagnostic investigations as 
described in the study protocol. In one patient a cav-
ernoma was not detected by investigations but was iden-
tified by repeated MRI during follow-up as part of the 
reference strategy. The median duration of follow-up of 
the 298 patients was 450 days (interquartile range 371-
1150 days). During this time seven patients had recur-
rent non-traumatic intracerebral haemorrhage; in none 
was a macrovascular cause found. Cerebral amyloid 
angiopathy was diagnosed in one of these patients after 
the initial clinical investigations and in another patient 
at the time of recurrent non-traumatic intracerebral hae-
morrhage, in two patients the presumed cause was 
hypertensive vasculopathy, and no underlying cause 
was found in three patients. Central reading of all imag-
ing detected one dural arteriovenous fistula that was not 
detected during local reading at the participating centre.
Table 2 lists the prevalences and prevalence ratios of 
a macrovascular cause according to the presence or 
absence of clinical and radiological characteristics.
radiological assessment
Assessment of 291 of the 298 patients (98%) was by CT 
angiography. In seven patients the quality of the images 
was insufficient for assessment (figure). CT angiogra-
phy was stopped in one patient who was unable to keep 
still; in the other six patients the vessels in the area of 
the haematoma were not depicted because CT angiogra-
phy was limited to the circle of Willis. MRI/MRA was 
successful in 255 patients (86%). Three of 154 digital 
subtraction angiograms were of insufficient quality for 
assessment. The main reason for not performing MRI/
MRA was immediate diagnostic and therapeutic inves-
tigation after a positive CT angiography result (see sup-
plementary box 2). The main reason for not performing 
digital subtraction angiography in patients with nega-
tive CT angiography results was an alternative diagno-
sis on MRI/MRA, or the reluctance of the patients or 
their treating doctors (see supplementary box 2). The 
median interval between non-contrast CT and CT angi-
ography was 1 day (interquartile range 0-2 days), 
between CT angiography and MRI/MRA was 46 (32-64) 
days, and between MRI/MRA and digital subtraction 
angiography was 33 (3-60) days.
Of the 291 CT angiograms assessed, 59 were scored as 
positive, 12 as inconclusive, and 220 as negative (figure).
Including inconclusive CT angiograms test results as 
positive, the positive predictive value was 74% (95% con-
fidence interval 62% to 84%) and the negative predictive 
value 92% (88% to 95%, table 3). In 51 of 298 patients a 
macrovascular cause was diagnosed with CT angiogra-
phy, resulting in a yield of 17% (13% to 22%), in 47 of these 
patients the CT angiography result was scored as positive 
and in four it was scored as inconclusive (table 3).
Additional MRI/MRA was performed in 214 of 232 
patients with a negative or inconclusive CT angiography 
test result. Of these 214 MRI/MRAs, six were scored as a 
positive result, 11 as inconclusive, and 197 as negative. 
With inconclusive MRI/MRA results included in the 
positive test results, the positive predictive value was 
32% (13% to 57%) and the negative predictive value was 
93% (89% to 96%). In 53 of 298 patients a macrovascu-
lar cause was detected by combined CT angiography 
and MRI/MRA, giving a yield of 18% (14% to 23%). In 51 
of these patients, MRI/MRA (or CT angiography) was 
scored as a positive result and in two patients the MRI/
MRA was scored as inconclusive.
Digital subtraction angiography was assessed in 103 
of 232 patients with negative or inconclusive CT angiog-
raphy test results, of whom 97 also had negative or 
inconclusive MRI/MRA test results. The result of digital 
subtraction angiography was positive in 13 of these 97 
patients (13%), resulting in a positive predictive value of 
100% (75% to 100%) and a negative predictive value of 
100% (96% to 100%) (table 3). The yield of combined CT 
angiography, MRI/MRA, and digital subtraction angiog-
raphy was 23% (18% to 28%), with a macrovascular 
cause detected in 68 of 298 patients. Table 4 lists the 
accuracy of the combination of CT angiography and 
MRI/MRA and of the combination of CT angiography, 
MRI/MRA, and digital subtraction angiography.
In 59 of 230 patients (26%) without a macrovascular 
cause, an alternative explanation for the non-traumatic 
intracerebral haemorrhage was found, mainly on MRI 
(table 1). None of the 63 patients with microbleeds had an 
underlying macrovascular cause (table 2). In two patients 
an incidental aneurysm was found that was unrelated to 
the non-traumatic intracerebral haemorrhage.
Complications
None of the patients had complications with CT angiog-
raphy or with MRI/MRA. Complications with digital 
table 1 | Causes of intracerebral haemorrhage in participants
Causes
no (%) of patients 
(n=298)
Macrovascular:
 Arteriovenous malformation 34 (11)
 Dural arteriovenous malformation 13 (4)
 Cavernoma 10 (3)
 Cerebral venous sinus thrombosis 4 (1)
 Aneurysm 7 (2)
 Developmental venous anomaly* 1 (0.3)
 Subtotal 69 (23)
Other:
 Probable cerebral amyloid angiopathy27 18 (6)
 Hypertensive vasculopathy† 36 (12)
 Neoplasm 3 (1)
 Cocaine use 1 (0.3)
 Haemorrhagic infarction 2 (0.7)
 Unknown‡ 169 (57)
 Subtotal 229 (77)
*Partially thrombosed large developmental venous anomaly without 
evidence of adjacent cavernoma.
†Intracerebral haemorrhage in basal ganglia, thalamus, or posterior 
fossa in presence of hypertension.
‡In 30 of these patients, lobar haemorrhage in the presence of 
hypertension was observed.
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subtraction angiography included a groin haematoma 
in three patients (2%) and (possible) thromboembolic 
complications in three patients (2%); one with transient 
aphasia, one with a permanent visual deficit (homony-
mous hemianopia), and one with transient decreased 
consciousness. The proportion of patients with a com-
plication resulting in permanent sequelae from the dig-
ital subtraction angiography was 0.6% (1/154).
Multivariable logistic regression
In the multivariable logistic regression model, 
non-traumatic intracerebral haemorrhage in the pos-
terior fossa was the strongest predictor (odds ratio 
13.0, 95% confidence interval 3.7 to 46.5, reference: 
basal ganglia or thalamus), followed by the absence 
of signs of small vessel disease on non-contrast CT 
(8.5, 2.9 to 25.3), lobar location of the non-traumatic 
table 2 | prevalences and prevalence ratios of a macrovascular cause in 298 patients with intracerebral haemorrhage 
according to presence or absence of clinical and radiological characteristics. Values are numbers (percentages) unless 
stated otherwise
Characteristics
Characteristic  
present
Characteristic  
absent
prevalence ratio  
(95% Ci)
Clinical characteristics
Age <50 years 42/112 (37.5) 27/186 (14.5) 2.58 (1.69 to 3.94)
Male sex 45/185 (24.3) 24/113 (21.2) 1.15 (0.74 to 1.77)
Glasgow coma score on admission:
 3-11 10/28 (35.7) 34/165 (20.6)* 1.73 (0.97 to 3.10)
 12-14 12/55 (21.8) 34/165 (20.6) 1.06 (0.59 to 1.90)
 Verbal score not applicable (aphasia) 13/50 (24.0) 34/165 (20.6) 1.26 (0.72 to 2.20)
Alcohol intake†:
 None 24/114 (21.1) 41/144 (28.5)‡ 0.74 (0.48 to 1.15)
 High (≥4/day) 4/36 (11.1) 41/144 (28.5) 0.39 (0.15 to 1.02)
Current smoking 20/72 (27.8) 49/226 (21.7) 1.28 (0.82 to 2.00)
Drug misuse before ICH§ 5/12 (41.7) 64/283 (22.6) 1.84 (0.91 to 3.73)
Hypertension 16/95 (16.8) 53/203 (26.1) 0.65 (0.39 to 1.07)
Diabetes mellitus¶ 1/18 (5.6) 68/279 (24.6) 0.23 (0.03 to 1.55)
Hypercholesterolemia** 5/26 (19.2) 37/176 (21.0) 0.91 (0.40 to 2.12)
History of CVD† 2/12 (16.7) 67/282 (23.8) 0.70 (0.19 to 2.53)
Family history of CVD†† 12/55 (21.8) 51/228 (22.4) 0.98 (0.56 to 1.70)
Oral anticoagulants§ 0/5 (0.0) 69/291 (23.7) P=0.59‡‡
Daily antiplatelet use 3/31 (9.7) 68/267 (25.5) 0.38 (0.13 to 1.14)
radiological characteristics
Non-contrast CT assessment:
 ICH location:
  Basal ganglia or thalamus 5/85 (5.9) 49/178 (27.5)§§ 0.21 (0.09 to 0.51)
  Posterior fossa 15/35 (42.9) 49/178 (27.5) 1.56 (0.99 to 2.44)
 ICH volume >11 mL (median) 34/148 (23.0) 35/150 (23.3) 0.98 (0.65 to 1.49)
 Subarachnoid haemorrhage 21/56 (37.5) 48/242 (19.8) 1.89 (1.24 to 2.88)
 Extension to frontal operculum 6/12 (50.0) 63/286 (22.0) 2.27 (1.24 to 4.16)
 Intraventricular extension 23/71 (32.4) 46/227 (20.3) 1.60 (1.05 to 2.44)
 Mass effect 45/191 (23.6) 24/107 (22.4) 1.05 (0.68 to 1.62)
 Oedema 39/192 (20.3) 30/107 (28.0) 0.72 (0.48 to 1.10)
 Haematoma density, homogeneous 55/239 (23.0) 14/59 (23.7) 0.97 (0.58 to 1.62)
 White matter lesions 4/113 (3.5) 65/185 (35.1) 0.10 (0.04 to 0.27)
 Hypodensity in basal ganglia, thalamus or posterior fossa 1/37 (2.7) 68/261 (26.1) 0.10 (0.01 to 0.72)
 Small vessel disease¶¶ 4/120 (3.3) 65/178 (36.5) 0.09 (0.03 to 0.24)
 Enlarged vessels along ICH margins 11/13 (84.6) 58/285 (20.4) 4.16 (3.00 to 5.76)
 Calcifications along ICH margins 7/7 (100.0) 62/291 (21.3) 4.69 (3.76 to 5.85)
 Hyperattenuation within dural venous sinus or cortical vein 6/10 (60.0) 63/288 (21.9) 2.74 (1.58 to 4.76)
MRI assessment:
 Microbleeds*** 0/63 (0.0) 40/163 (24.5) P<0.01‡‡
 Previous ICH*** 0/30 (0.0) 40/196 (20.4) P<0.01‡‡
 White matter lesions††† 9/147 (6.1) 34/109 (31.2) 0.20 (0.10 to 0.39)
 Previous infarct††† 1/70 (1.4) 42/186 (22.6) 0.06 (0.01 to 0.45)
ICH=intracerebral haemorrhage; CVD=cardiovascular disease; CT=computed tomography; MRI=magnetic resonance imaging.
*15 was taken as reference.
†Missing values for four patients.
‡Sporadic or moderate was taken as reference.
§Missing values for three patients.
¶Missing values for one patient.
**Total cholesterol concentration was available for 202 patients, cut-off value 5.6 mmol/L.
††Missing values for 15 patients.
‡‡P value Fisher’s exact test.
§§Lobar was taken as reference.
¶¶Defined as presence of white matter lesions, or an ischaemic lesion in basal ganglia, thalamus, or posterior fossa.
***Assessment possible for 226 patients.
†††Assessment possible for 256 patients.
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intracerebral haemorrhage (5.5, 2.0 to 15.3), and age 
(0.96, 0.93 to 0.99).
discussion
This study shows that in preselected patients with 
non-traumatic intracerebral haemorrhage, the overall 
yield of CT angiography and MRI/MRA for detection of a 
macrovascular cause is slightly higher than that of early 
CT angiography as a single modality (18% v 17%), 
whereas the overall yield is increased to 23% by the com-
bination of CT angiography, MRI/MRA, and digital sub-
traction angiography. After a negative CT angiography 
result, MRI/MRA can identify patients with a cavernoma 
or an alternative diagnosis such as a neoplasm or cere-
bral amyloid angiopathy, but is not useful to exclude an 
arteriovenous malformation or dural arteriovenous fis-
tula. Digital subtraction angiography is accurate in the 
detection of arteriovenous malformations and dural 
arteriovenous fistula in patients in whom the underlying 
cause was not found by CT angiography and MRI/MRA.
Non-traumatic intracerebral haemorrhage located in 
the posterior fossa or lobar region is an important pre-
dictor of an underlying macrovascular cause, as is 
absence of small vessel disease on initial non-contrast 
CT. The probability of finding an underlying macrovas-
cular cause diminishes with increasing age.
Based on the finding that all but one macrovascular 
lesions was detected at local reading, a strategy with 
independent assessment of vascular imaging studies by 
a second reader is not indicated.
Diagnostic strategies in patients with non-traumatic 
intracerebral haemorrhage vary among specialties and 
countries.13  Some have suggested CT angiography as the 
initial examination,22  whereas others prefer to start with 
magnetic resonance.23  A recent Cochrane review 
reported high accuracy for MRI/MRA for detection of 
macrovascular causes of non-traumatic intracerebral 
haemorrhage as a first diagnostic modality.24 In our 
study, MRI/MRA was performed four to eight weeks after 
non-traumatic intracerebral haemorrhage in patients in 
whom CT angiography had not found a cause of the hae-
morrhage. Therefore, our study does not provide infor-
mation on the diagnostic accuracy of MRI/MRA as an 
initial investigation after non-contrast CT.
In this study, none of the patients with microbleeds 
had a macrovascular cause for non-traumatic intracere-
bral haemorrhage. The predictive value of microbleeds 
independently of signs of small vessel disease on 
non-contrast CT cannot be determined from our study 
because not all patients with negative CT angiography 
results and microbleeds on MRI underwent digital sub-
traction angiography.
CTA inconclusive (n=12)
MRA assessment (n=11)
CTA negative (n=220)
Eligible patients (n=302)
Included patients (n=298)
CTA results (n=291)
CTA positive (n=59)
DSA assessment (n=44):
  Negative (n=23)
  Aneurysm (n=4)
  AVM (n=10)
  DAVF (n=7)
MRA positive
(n=1)
MRA negative
(n=4)
MRA
inconclusive
(n=6)
DSA assessment
  (n=3):
  Negative (n=2)
  Positive (n=1)
  (AVM)
DSA assessment (n=89):
  Negative (n=79)
  Positive (n=10)
  (7 AVM, 3 DAVF)
* An underlying cavernoma was identied
by repeated MRI 10 months aer the ictus
MRA = magnetic resonance angiography
CTA = computed tomography angiography
DSA = digital subtraction angiography
AVM = arteriovenous malformation
CVST = cerebral venous sinus thrombosis
DAVF = dural arteriovenous stula
DVA = developmental venous anomaly
MRI = magnetic resonance imaging
DSA assessment positive (n=1) (AVM)
No DSA
(n=3)
DSA assessment
  (n=3):
  Negative (n=1)
  Positive (n=2)
  (2 AVM)
No DSA
(n=1)
DSA assessment
  Negative (n=1)
MRA positive
(n=5)
Cavernoma (n=3)
DSA assessment
  (n=1):
  AVM (n=1)
No DSA
(n=4)
No DSA
(n=3)
DSA
assessment
 Negative
(n=2)
No DSA
(n=101)*
DSA unsuitable for
assessment (n=3)
Excluded (n=4):
  Contraindication for MRA (n=1)
  No CTA performed (n=3)
CTA assessment not possible (n=7):
  CTA failed (n=1)
  CTA of insucient quality (n=6)
Further assessment
(7 MRA, 4 DSA)
(n=7 negative)
No further tests
  (n=14):
  Refusal (n=10)
  Deceased (n=4)
MRA negative
(n=193)
MRA assessment
(n=203)
DSA assessment
  (n=3):
  Negative (n=1)
  AVM (n=1)
  DAVF (n=1)
MRA inconclusive (n=5)
Repeated MRI
  Positive (n=1)
(cavernoma)
MRA assessment
  (n=34):
  Negative (n=13)
  Aneurysm (n=1)
  AVM (n=9)
  Cavernoma
    (n=5)
  CVST (n=3)
  DAVF (n=2)
  DVA (n=1)
Treatment, no
  further tests
  (n=5):
  Aneurysm (n=2)
  AVM (n=2)
  CVST (n=1)
Flow chart of angiographic examinations carried out between July 2008 and July 2014
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Absence of hypertension is a known predictor of an 
underlying macrovascular cause,6-8  which could not be 
shown in the present study. This is not surprising as we 
excluded patients older than 45 years with a haemor-
rhage in the basal ganglia, thalamus, or posterior fossa 
in the presence of hypertension, and therefore in our 
study the prevalence of hypertension was relatively low 
compared with that of other studies.5 7 25
Strengths and weaknesses of this study
The strengths of this study are the prospective design and 
the standardised investigations using CT angiography, 
MRI/MRA, and digital subtraction angiography in a rela-
tively large cohort of patients in a large number of hospi-
tals. Other strengths are centralised reading, including 
quality control of the scans at the same time as allowing 
some variation in scanning variables. The participation of 
both general and university hospitals and the pragmatic 
approach contribute to the external validity of our results.
The pragmatic design of this study also has its limita-
tions. We excluded patients older than 70 years, as there 
was little chance of finding a macrovascular cause.7 8 
Therefore we could not assess if any determinants could 
identify which elderly patients should undergo additional 
digital subtraction angiography. Another limitation is that 
not all patients with negative CT angiography and MRI/
MRA results underwent digital subtraction angiography. 
This is largely attributable to the reluctance of the patients 
and their treating clinicians because of the (small) risk of 
complications with digital subtraction angiography. 
Although the previous probability of finding a macrovascu-
lar cause was lower in patients in whom no digital subtrac-
tion angiography was performed, as they were on average 
older and more often had a deep non-traumatic intracere-
bral haemorrhage, we cannot rule out missing some small 
arteriovenous malformations or dural arteriovenous fistu-
las. Another limitation is the validity of the best available 
evidence as a reference standard, which incorporated the 
results of all performed tests, information from neurosurgi-
cal inspection, pathological examination, and additional 
findings during one year’s follow-up.
Longer term follow-up data or repeated investiga-
tions in all patients could have provided additional 
information on detection of macrovascular causes after 
the initial diagnostic investigations.
Findings in context of similar studies
A Cochrane review reported a high sensitivity (pooled esti-
mate 0.95, 95% confidence interval 0.90 to 0.97) and spec-
ificity (0.99, 0.95 to 1.00) of CT angiography,24  but the 
authors noted that the test accuracy was probably inflated 
by methodological shortcomings in the included studies. 
In our study, the sensitivity (74%) and specificity (91%) of 
CT angiography were indeed lower than previously 
reported.3 5 24 26  This can be related to differences in both 
study populations and outcomes between our study and 
that of others. In one previous study, the population was 
younger (mean age 48 years), and thus more selected, 
resulting in a prevalence of macrovascular causes as high 
as 33%.26  Two other studies,3 5  both with a retrospective 
design, reported on a less selected population with t
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8
 macrovascular causes and found prevalences of 13%5  and 
15%,3  and therefore more true negative results. Another 
explanation for the lower sensitivity and specificity of CT 
angiography in our study compared with that of previous 
studies,3 5 26 is that we regarded an underlying cavernoma 
as a positive outcome; half of the detected cavernomas in 
our study were not identified on early CT angiography.
implications
Our results indicate that CT angiography is an appropri-
ate initial investigation for non-traumatic intracerebral 
haemorrhage, as it identifies around three quarters of 
macrovascular causes of such haemorrhages, is widely 
available, is feasible in patients with a poor clinical con-
dition on admission, and has few complications (none in 
our study). However, we found that the accuracy of CT 
angiography is lower than previously reported. Addi-
tional MRI/MRA rarely detects additional macrovascular 
causes after a negative CT angiography result but it does 
provide important information on alternative diagnoses 
such as cerebral amyloid angiopathy. Digital subtraction 
angiography is able to detect with high accuracy small 
macrovascular causes not detected by CT angiography.
unanswered questions and future research
Future research will be helpful to establish the diagnos-
tic value of MRI/MRA as an initial diagnostic modality 
after non-contrast CT, and to determine whether further 
evaluation with digital subtraction angiography is indi-
cated in patients with microbleeds on MRI.
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Web appendix: box showing assessed radiological 
characteristics on admission non-contrast computed 
tomography, and box showing reasons for not 
performing MRI/MRA and digital subtraction 
angiography in patients with negative or inconclusive 
CT angiography results
